Browse Items (2 total)
Sort by:
This site uses Google Analytics to track site traffic and other metrics. If you would like to allow the use of Google Analytics please click Opt In below. This will associate a cookie with your browser.
Tags: 0 (Antioxidants), 2005, 2208-40-4 (6-sulfatoxymelatonin), Administration Oral, Adolescent, Antioxidants, Antioxidants/ad [Administration & Dosage], Antioxidants/pk [Pharmacokinetics], Case-Control Studies, characteristics, Child, Child Preschool, Circadian Rhythm, English J, Female, Hancock E, Humans, JL5DK93RCL (Melatonin), Journal of Child Neurology, Male, melatonin, Melatonin/aa [Analogs & Derivatives], Melatonin/ad [Administration & Dosage], Melatonin/pk [Pharmacokinetics], Melatonin/ur [Urine], O'Callaghan F, Osborne J P, Reference Values, sleep disturbance/disorders, Sleep Wake Disorders, Sleep Wake Disorders/co [Complications], Sleep Wake Disorders/pp [Physiopathology], Trajectory, Tuberous Sclerosis, Tuberous Sclerosis/co [Complications], Tuberous Sclerosis/pp [Physiopathology]
Tags: 2013, Angelman Syndrome/co [Complications], Angelman Syndrome/dt [Drug Therapy], Anticonvulsants/ad [Administration & Dosage], Anticonvulsants/ae [Adverse Effects], Anticonvulsants/tu [Therapeutic Use], Backlog, Epilepsies, Faulkner MA, Humans, Journal Article, KT Synthesis, Myoclonic/co [Complications], Myoclonic/dt [Drug Therapy], Pharmacotherapy, Rett Syndrome/co [Complications], Rett Syndrome/dt [Drug Therapy], Seizures/co [Complications], Seizures/dt [Drug Therapy], Singh Sanjay P, Treatment Outcome, Tuberous Sclerosis/co [Complications], Tuberous Sclerosis/dt [Drug Therapy]